These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A; Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167 [TBL] [Abstract][Full Text] [Related]
26. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications]. Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875 [TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender. Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770 [TBL] [Abstract][Full Text] [Related]
28. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas. Maiuri F; Del Basso De Caro ML; Iaconetta G; Peca C; Esposito M; de Divitiis E Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834 [TBL] [Abstract][Full Text] [Related]
29. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine. Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687 [TBL] [Abstract][Full Text] [Related]
30. Expression of cyclooxygenase-1 and -2 in human breast cancer. Yoshimura N; Sano H; Okamoto M; Akioka K; Ushigome H; Kadotani Y; Yoshimura R; Nobori S; Higuchi A; Ohmori Y; Nakamura K Surg Today; 2003; 33(11):805-11. PubMed ID: 14605950 [TBL] [Abstract][Full Text] [Related]
31. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Kitange G; Misra A; Law M; Passe S; Kollmeyer TM; Maurer M; Ballman K; Feuerstein BG; Jenkins RB Genes Chromosomes Cancer; 2005 Jan; 42(1):68-77. PubMed ID: 15472895 [TBL] [Abstract][Full Text] [Related]
32. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas. Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461 [TBL] [Abstract][Full Text] [Related]
33. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907 [TBL] [Abstract][Full Text] [Related]
34. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer. Seo SS; Song YS; Kang DH; Park IA; Bang YJ; Kang SB; Lee HP Gynecol Oncol; 2004 Mar; 92(3):927-35. PubMed ID: 14984962 [TBL] [Abstract][Full Text] [Related]
35. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. Miller CR; Dunham CP; Scheithauer BW; Perry A J Clin Oncol; 2006 Dec; 24(34):5419-26. PubMed ID: 17135643 [TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 expression in human pituitary tumors. Vidal S; Kovacs K; Bell D; Horvath E; Scheithauer BW; Lloyd RV Cancer; 2003 Jun; 97(11):2814-21. PubMed ID: 12767095 [TBL] [Abstract][Full Text] [Related]
37. Expression of DNA topoisomerase IIalpha in oligodendroglioma. Bredel M; Gatterbauer B; Birner P; Haberler C; Ströbel T; Budka H; Rössler K; Hainfellner JA Anticancer Res; 2002; 22(2B):1301-4. PubMed ID: 12168941 [TBL] [Abstract][Full Text] [Related]
38. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy. Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710 [TBL] [Abstract][Full Text] [Related]
40. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study. Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]